Treatment
Treatment Phoneline
0808 800 6013 Mon-Wed 12-4pm
Hepatitis C and HIV – May 2007
Characteristic | HIV | HCV |
|---|---|---|
Type of virus and how transmitted | Bloodborne. Also present in semen, vaginal fluid and breast milk | Bloodborne. Also may be present in semen and vaginal fluid |
Whether sexual transmission occurs | Sexual transmission common | Sexual transmission less common, especially among heterosexual couples, but does occur among HIV-positive gay men |
Risk of mother-to-child transmission (MTCT) | Risk of mother-to-child transmission can be dramatically reduced with use of antiretroviral therapy | Risk of MTCT of HCV is higher if you are HIV-positive. In the UK, women with coinfection are recommnded to have an elective C-section to lower the risk. |
Risk from breastmilk | Breast feeding can transmit HIV | Risk of HCV transmission from breast feeding is considered very low (unless mother’s nipples are cracked or bleeding) |
Whether lifelong | Yes (at time of writing) | Not always chronic (can be cleared/ cured) |
Risk of reinfection | Reinfection with HIV happens. In many cases it may not have serious implications unless the new virus is drug resistant (cases of reinfection with drug-resistant HIV have been reported, but no one is sure how often this happens). HIV reinfection is the subject of current research. | Reinfection with hepatitis C occurs, and being reinfected with a different genotype may make it more difficult to treat. For example, if someone with HCV genotype 2 is reinfected with HCV genotype 1. Clearing the virus with a natural immune response or with treatment doesn’t protect you from reinfection in the future. |
How infectious outside the body | HIV is a fragile virus. Dies quickly when outside of the human body | HCV is a tougher virus. Can live for days outside of the human body. |
Is treatment always needed? | Treatment is not always necessary, but it is needed by the majority of people at some time. Less than 5% people still have not needed to start treatment 15 years after infection. | Treatment is not always necessary. Some people clear the virus naturallly and some people do not get symptoms even in chronic infection. |
Speed of progression | People can live with HIV for many years without symptoms (average 5-8 without treatment). | People can live with HCV for many years without symptoms (average over 10-15 for people with coinfection). |
Effect of treatment on viral load | Levels of HIV in the blood can be suppressed by treatment. | HCV can be virtually eradicated from the bloodstream if treatment is successful. |
Duration of treatment | Treatment can be lifelong. | Treatment usually lasts for a year or less. |
Impact of viral load on how fast the disease progressed | Viral load is linked to disease progression. | Viral load is linked to treatment response, but not disease severity or progression. |
Choice of treatment | More than 20 drugs available, that specifically target the virus. | Currently, standard of care is combination therapy with pegylated interferon plus ribavirin, two drugs that do not specifically target the virus. |
Research pipeline | Drugs from new classes and existing classes are currently in development. | Drugs from new and existing classes are currently in development. |
This is the web edition of the i-Base guide Hepatitis C for people living with HIV: testing,
coinfection, treatment and support. This guide is available in UK clinics.
You can order
free printed copies or download a PDF version (657 Kb).
Information on this website is provided as a guide only. All treatment decisions should be taken in consultation with your doctor or other healthcare professional. Authors and credits. Full section index. Glossary.
Top | i-Base guides | Home | Order & subscribe | Contact | Site map | Access
Hepatitis C Trust Helpline 0870 200 1 200 Mon-Fri 12-6pm (Thu 7pm) Calls charged at national rate